Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001214659-19-006961
Filing Date
2019-11-08
Accepted
2019-11-08 16:30:18
Documents
1
Period of Report
2019-11-06

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-46066.html 4  
1 PRIMARY DOCUMENT marketforms-46066.xml 4 7642
  Complete submission text file 0001214659-19-006961.txt   9136
Mailing Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608
Business Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608 510-204-7239
XOMA Corp (Issuer) CIK: 0000791908 (see all company filings)

EIN.: 522154066 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2910 SEVENTH STREET BERKELEY CA 94710
Business Address
Neal James R (Reporting) CIK: 0001600865 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-14710 | Film No.: 191204435